C reatine transporter deficiency (CTD) is a rare, X-linked single gene disorder, and 1 of 3 cerebral creatine deficiency syndromes. 1 Children with CTD experience significant developmental delays, including minimal verbal development, intellectual disability, motor dysfunction, and seizures. Preliminary diagnosis is possible by measuring creatine and related metabolites in blood and/or urine, or by proton magnetic resonance spectroscopy. 2 A definitive diagnosis is made by sequencing SLC6A8 and creatine uptake studies. CTD does not result in life-threatening conditions early in life. There is no routine procedure in primary care that would identify CTD in infants. The literature suggests most diagnosis would be made before 3 years of age. 3 We interviewed families and reviewed the available medical records in a retrospective sample to determine their actual age at diagnosis, the developmental course and the earliest signs of CTD, and the path to diagnosis experienced by families.
Methods
Twenty boys with genetic confirmation of CTD based on pathologic mutation in the SLC6A8 gene from 17 families participated (known cases range from 200 to 250 globally). Participants were 1.2-20.11 years of age (mean, 9.6 ± 5.8 years). Racial and ethnic breakdown was 75% white/non-Hispanic, 10% Asian, 10% black, and 5% Hispanic. Parents participated in an extensive, open-ended interview about pregnancy, delivery, early development, first concerns, concerns in hindsight, and current functioning. Parents provided access to medical records for review and home videos of participants at different ages. Seven participants were also evaluated in person. Content from the interviews and medical records informed the creation of a CTD developmental history interview for ongoing research (available from the authors). Families were also interviewed with the Vineland Adaptive Behavior Scales Survey Form, Second Edition. 4 The Institutional Review Boards at The Children's Hospital of Philadelphia and National Institute of Child Health and Development approved this study.
Results

Age at Diagnosis
A diagnosis of CTD before age 42 months only occurred when the family history was known at birth (2 of the 3) or an early seizure (2 of 6 with seizures) or early change in balance and coordination (n = 1). Seizures prompted an earlier diagnosis in general (average age of 68 months vs 111 months; Table) .
Pregnancy and Delivery
Complications were rare and minor. The most significant was mild heart rate decelerations during labor in 1 participant, later attributed to an anomalous insertion of the umbilical cord into the placenta.
Development from 0-11 Months of Age (n = 20)
Ten of the 20 participants had both a feeding or weight gain issue (8 with projectile vomiting and very slow weight gain, 2 with slow weight gain and very low energy) as well as an early delayed milestone (sitting up or crawling). Four more children had either one or the other. One had a seizure without other early signs. Six families tried prescription-based formulas, with limited success. Eight children would eventually be diagnosed with failure to thrive or have a feeding tube placed. Although the benefit of hindsight suggests that 15 children had at least 1 early indicator, parents of only 8 children were significantly concerned at the time, and only 3 children were referred to early intervention. The 2 children diagnosed before their first birthday had a known family history. Vomiting resolved in all but 2 children by 12 months of age. However, 18 of 19 children failed to walk on time (15 walked at >24 months). Seven children had their first apparent seizure (by parent report or neurologic examination) between 12 and 24 months; 5 of these children had shown both early vomiting and motor delays. By 24 months of age, all parents were significantly concerned about delays in motor milestones, lack of babbling or speech sounds (n = 12), persistent feeding problems but no longer vomiting (n = 9), seizures (n = 6), or activity level (n = 2). However, only 7 children enrolled in early intervention during this time period, for a cumulative total of 10 of the 20 children in early intervention. No children were diagnosed between 12 and 24 months of age.
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Development from 24-36 Months of Age (n = 18) All children were walking by age 36 months, but at least 1 child had ataxia and at least 1 child had a very unusual gait; other motor delays were also present. Only 1 child continued to experience significant vomiting (which has continued through childhood). All 18 continued to show no or minimal language development. Four children were referred to early intervention for the first time, for a cumulative total of 14 of the 20 children being in early intervention. Two children had their first seizure and a third had a sudden change in coordination that prompted immediate evaluation (but no seizure activity was detected); 2 of these children received the CTD diagnosis during this period.
Pathway to a CTD Diagnosis
Of the 20 children, 3 had a family history that prompted testing, and one was found through a research study specifically screening for CTD in children with autism or intellectual disability. 5 Six had a seizure and 1 had a sudden change in balance that led to a specialist referral. Otherwise, 6 had parents who actively sought specialty care despite a reported lack of concern from primary care providers; 4 had a provider refer for specialty care based on developmental concerns. Specialty providers included neurology, genetics, and developmental and behavioral pediatrics, with each discipline associated with some catches and some misses.
Current Presentations
Current ages ranged from 14 months to 20 years. Although still severely impaired, the individuals in our sample continued to learn new skills. The 2 adults both developed phrase speech for the first time in late adolescence. However, across the sample verbal skills remained limited: 4 used some phrase speech, 9 used only single words, and 7 had no expressive language. Home videos and parent report indicated that children understood at least some aspects of complex conversations happening around them. Independent daily living skills remained very low, with all standard scores on the Vineland ranging between 28 and 69 (population mean, 100 ± 15). With regard to behavior, 9 families reported current behavior challenges, including self-injury (n = 8), throwing objects (n = 7), tantrums (n = 7), and aggression toward other children (n = 5). Six had a community diagnosis of autism spectrum disorder. With regard to medical issues, 4 used feeding tubes and 1 continued to have significant seizures. We did not gather systematic information about current use of medications or supplements.
Current Parent Concerns and Child Strengths
Parents reported relative strengths in receptive language, and a generally happy mood in young children (n = 13). The parents of adults (n = 2) indicated significant emotional dysregulation in adolescence, which subsided in adulthood. Top concerns were independence (n = 14) and communication (n = 10). Almost all still need assistance with basic self-help skills such as toileting, dressing, and bathing. Challenging behaviors were a concern for some (n = 5), followed by seizures (n = 5), and vomiting (n = 1).
Discussion
Very early feeding or weight gain issues (significant vomiting or failure to thrive) and motor delays (sitting or crawling) could have potentially alerted providers to seek a specialty referral and/or conduct a urine screen for one-half of the study participants with CTD. Urine screens are not perfect, but can be effective as early as age 1 month. 2 However, most of our participants were diagnosed after a seizure or only after years of delayed development. Although this study is limited to retrospective parent report and medical record review, it is informative because the sample comprises possibly 10% of all known cases, and it presents an in-depth look at the sequence of events that ultimately led to an accurate diagnosis.
Although feeding issues and delayed milestones are not very specific indicators, the clinical guidance available (www.medlineplus.gov; www.healthychildren.org; www .uptodate.com) provides very little guidance about the possibility of a rare metabolic condition in infancy. Online information about infant emesis or vomiting points to reflux, illness, allergy, or pyloric stenosis, although vomiting is known to occur in other neurometabolic conditions. [6] [7] [8] Furthermore, parents and providers need more tools to reach a consensus on what constitutes vomiting vs reflux, such as showing videotapes of the behavior to a physician.
Current guidance about failure to thrive 9 also does not alert families or providers to consider a rare metabolic condition. Widespread guidance is still based on a landmark study from 1978, 10 which concluded that any medical explanation for failure to thrive will be identifiable from the history and physical examination, with no extra value provided by laboratory screening tests. Our data suggest that considering the possibility of rare metabolic disorders could lead parents and providers to an earlier diagnosis. Similar calls have been proposed to view early life epilepsy as a possible signal of a genetic disorder rather than a separate condition. 11 Finally, we report a metabolic condition where infant vomiting may resolve with the introduction of solid food. Specialists evaluating an older child might not even ask about vomiting in early infancy if it has resolved (solid foods reduce reflux for many babies), but combined with other early delays significant infant vomiting may be diagnostically relevant and suggest a metabolic condition. Further research should examine possible mechanisms of vomiting in these patients, particularly including whether it could be due to hypotonia, since there are often other motor delays in CTD. Other possible considerations include esophageal sphincter dysfunction or delayed gastric emptying, but we have not examined those specifically. More generally, gastrointestinal problems could be added to the section on metabolic testing in guidelines for genetic testing in children with intellectual disability or developmental delay. [12] [13] [14] We encourage pediatricians to closely monitor children with delayed basic milestones, significant feeding or weight gain issues, vomiting, or failure to thrive and consider a urine screen or genetics referral. CTD is a rare condition, but complacency may significantly delay diagnosis. We also recommend information about CTD for pediatricians be included on prominent websites and within resources available from the American Academy of Pediatrics. ■ 
